Omega Protein Corporation  

(Public, NYSE:OME)   Watch this stock  
Find more results for OME
11.13
+0.10 (0.91%)
Real-time:   10:19AM EDT
NYSE real-time data - Disclaimer
Currency in USD
Range 11.05 - 11.17
52 week 5.88 - 11.21
Open 11.10
Vol / Avg. 13,323.00/165,038.00
Mkt cap 221.67M
P/E 44.69
Div/yield     -
EPS 0.25
Shares 19.92M
Beta 2.00
Inst. own 75%
Aug 5, 2013
Q2 2013 Omega Protein Corp Earnings Release Add to calendar
May 9, 2013
Omega Protein Corp at Robert W Baird and Co Growth Stock Conference
May 8, 2013
Q1 2013 Omega Protein Corp Earnings Conference Call
Apr 29, 2013
Q1 2013 Omega Protein Corp Earnings Release
Apr 9, 2013
Omega Protein Corp Conference Presentation
Mar 6, 2013
Q4 2012 Omega Protein Corp Earnings Conference Call
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '13) 2012
Net profit margin 5.82% 1.72%
Operating margin 9.65% 5.36%
EBITD margin - 16.00%
Return on average assets 3.87% 1.42%
Return on average equity 5.50% 2.02%
Employees 500 -
Carbon Disclosure Rating - -

Address

Suite 500, 2105 City West Blvd
HOUSTON, TX 77042
United States - Map
+1-713-6230060 (Phone)
+1-713-9406122 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

Omega Protein Corporation is a nutritional ingredient company. The Company is a vertically integrated producer of Omega-3 fish oil and specialty fish meal products. The Company is a producer of protein-rich meal and oil derived from marine sources. The Company�s products are produced from menhaden (a herring-like fish found in commercial quantities), and include regular grade and value-added specialty fish meals, crude and refined fish oils and fish solubles. The Company produces and sells a variety of protein and oil products derived from menhaden, a species of wild herring-like fish found along the Gulf of Mexico and Atlantic coasts. It markets several grades of fish meal, as well as fish oil and fish solubles. The Company operates through two primary industry segments: animal nutrition and human nutrition. Effective February 27, 2013, the Company acquired Wisconsin Specialty Protein LLC.

Officers and directors

Gary R. Goodwin Chairman of the Board
Age: 64
Bio & Compensation  - Reuters
Bret D. Scholtes President, Chief Executive Officer, Director
Age: 43
Bio & Compensation  - Reuters
Andrew C. Johannesen Chief Financial Officer, Executive Vice President
Age: 45
Bio & Compensation  - Reuters
Matthew W. Phillips President of Cyvex Nutrition, Inc.
Age: 42
Bio & Compensation  - Reuters
John D. Held Executive Vice President, General Counsel, Secretary
Age: 50
Bio & Compensation  - Reuters
Mark Edward Griffin Senior Vice President - R&D and Sales and Marketing
Age: 44
Bio & Compensation  - Reuters
Gregory P. Toups Vice President, Chief Accounting Officer, Corporate Controller
Age: 37
Bio & Compensation  - Reuters
Gary L. Allee Presiding Independent Director
Age: 67
Bio & Compensation  - Reuters
Paul M. Kearns Independent Director
Age: 48
Bio & Compensation  - Reuters
William E. M. Lands Independent Director
Age: 81
Bio & Compensation  - Reuters